全文获取类型
收费全文 | 18293篇 |
免费 | 2163篇 |
国内免费 | 763篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 310篇 |
妇产科学 | 274篇 |
基础医学 | 1849篇 |
口腔科学 | 553篇 |
临床医学 | 1633篇 |
内科学 | 2741篇 |
皮肤病学 | 105篇 |
神经病学 | 1035篇 |
特种医学 | 789篇 |
外国民族医学 | 6篇 |
外科学 | 4123篇 |
综合类 | 2746篇 |
现状与发展 | 3篇 |
预防医学 | 1641篇 |
眼科学 | 418篇 |
药学 | 1292篇 |
3篇 | |
中国医学 | 656篇 |
肿瘤学 | 935篇 |
出版年
2024年 | 24篇 |
2023年 | 227篇 |
2022年 | 431篇 |
2021年 | 722篇 |
2020年 | 642篇 |
2019年 | 635篇 |
2018年 | 621篇 |
2017年 | 533篇 |
2016年 | 526篇 |
2015年 | 561篇 |
2014年 | 1074篇 |
2013年 | 1231篇 |
2012年 | 1002篇 |
2011年 | 1117篇 |
2010年 | 921篇 |
2009年 | 1012篇 |
2008年 | 1022篇 |
2007年 | 1041篇 |
2006年 | 966篇 |
2005年 | 983篇 |
2004年 | 842篇 |
2003年 | 723篇 |
2002年 | 615篇 |
2001年 | 535篇 |
2000年 | 483篇 |
1999年 | 396篇 |
1998年 | 301篇 |
1997年 | 296篇 |
1996年 | 244篇 |
1995年 | 213篇 |
1994年 | 158篇 |
1993年 | 149篇 |
1992年 | 132篇 |
1991年 | 105篇 |
1990年 | 86篇 |
1989年 | 53篇 |
1988年 | 62篇 |
1987年 | 53篇 |
1986年 | 40篇 |
1985年 | 76篇 |
1984年 | 66篇 |
1983年 | 62篇 |
1982年 | 48篇 |
1981年 | 52篇 |
1980年 | 45篇 |
1979年 | 24篇 |
1978年 | 19篇 |
1977年 | 20篇 |
1976年 | 11篇 |
1973年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
61.
Clanton C. Shipp Paul S. Berger Manya S. Deehr Bess Dawson-Hughes M.D. 《Calcified tissue international》1988,42(5):287-292
Summary Precision of dual-photon absorptiometry (DPA) measurements was determined in a lumbar spine phantom and in humans. Approximately
half of the measurements were made before and half after a153gadolinium source change. The phantom was measured with different amounts of acrylic, which simulates human soft tissue, in
order to evaluate the influence of body thickness on bone mineral density (BMD). Results of scans analyzed with two software
versions from Lunar Radiation Corp., the widely used 08B and a prototype 08C, are compared. DPA with a cold source significantly
overestimated BMD in the phantom in the presence of large amounts (more than 25 cm) of soft tissue equivalent with version
08B but not with the newer version 08C. Similiarly, in nine subjects, there was a significant decrease in spine BMD after
a source change when scans were analyzed with version 08B (mean difference 0.026 g/cm2,P=0.002) but not with 08C (0.01 g/cm2,P=0.234). No systematic effect of source change on femoral BMD measurements was observed. The SD of the mean difference of
two measurements of the nine subjects was 0.019 g/cm2 (1.6% of the mean value) for the spine with software version 08B and 0.024 g/cm2 (2.0%) with version 08C, 0.03 g/cm2 (3.3%) for the femur neck, 0.03 g/cm2 (4.0%) for the greater trochanter, and 0.04 g/cm2 (4.9%) for Ward's triangle region of the proximal femur. The spine phanton was scanned on two other commercial bone densitometers
in order to assess inter-instrument variation. Phantom measurements of L2-4 BMD made on two Lunar Radiation Corp model DP3
scanners which differed by 2% were 10 and 12% higher than those with a Norland Corp. model 2600 scanner. 相似文献
62.
固生蛋白tenascin对肝细胞癌血管生成及浸润转移的影响 总被引:1,自引:0,他引:1
目的 探讨固生蛋白(tenascin ,TN)在肝细胞癌(hepatocellularcarcinoma ,HCC)中的表达和与HCC血管生成及浸润转移的关系。方法 应用免疫组织化学法检测4 2例HCC、10例肝硬化和7例正常肝组织内TN的表达情况,观察与HCC病理学特点及微血管密度(microvesseldensity ,MVD)之间的关系。结果 ①TN在HCC中的阳性表达率和强度显著高于肝硬化和正常肝脏组织( χ2 =4 15 ,P <0 0 5 ;t=2 4 73,P <0 0 5 ) ;②TN在有包膜侵犯组、病理分级Ⅲ~Ⅳ组及有转移HCC中的阳性表达率及强度明显高于无包膜侵犯组( χ2 =5 4 7,P <0 0 5 ;t=2 138,P <0 0 5 )、病理分级Ⅰ~Ⅱ级组( χ2 =6 87,P <0 0 1;t=2 4 79,P <0 0 5 )以及无转移组( χ2 =10 6 ,P <0 0 1;t=2 6 93,P <0 0 1) ;③肝癌>5cm、有包膜侵犯、有转移、病理分级Ⅲ~Ⅳ级组的MVD值明显高于肝癌≤5cm(t=2 0 36 ,P <0 0 5 )、无包膜侵犯(t =2 32 8,P <0 0 5 )、无转移(t =2 4 94 ,P <0 0 5 )及病理分级Ⅰ~Ⅱ级组(t =2 2 71,P <0 0 5 )。④TN阳性表达HCC中的MVD值明显高于TN阴性表达HCC中的MVD值(t =2 4 87,P <0 0 5 )。结论 TN在HCC组织中的表达上调与其血管生成和浸润转移有关 相似文献
63.
目的探讨低密度及氧化低密度脂蛋白对内皮细胞分泌肾上腺髓质素(ADM)的影响.方法利用培养的内皮细胞株ECV-304细胞,分别与不同浓度的低密度(50 100mg/L)、氧化低密度脂蛋白(50 100mg/L)及低密度脂蛋白(50 mg/L) 氧化低密度脂蛋白(50 mg/L)进行孵育,24 h后分别收集培养上清及细胞,用放免分析检测上清及细胞内肾上腺髓质素的含量.结果低密度脂蛋白对肾上腺髓质素的分泌无影响,而氧化型低密度脂蛋白能明显刺激ADM的分泌,二者合用的作用接近于100mg/L的OX-LDL.结论OX-LDL可能具有氧化LDL使其成为OX-LDL的作用,ADM的分泌可能是对细胞损伤的一种反应. 相似文献
64.
Christina Djokoto George Tomlinson Stephen Waldman Marc Grynpas Angela M. Cheung 《Journal of clinical densitometry》2004,7(4):448-456
Dual-energy X-ray absorptiometry (DXA) and quantitative ultrasound (QUS) are the accepted modalities for the evaluation of fracture risk in the clinical setting. However, neither method provides a direct measurement of bone mechanics. In this study, we investigated a prototype device, known as a mechanical response tissue analyzer (MRTA), which provides direct mechanical measurements of mechanical properties of bone. A total of 56 healthy volunteers (20 men and 36 women) between the ages of 18 and 83 were recruited. The MRTA was used to measure the cross-sectional bending stiffness (EI) of the ulna bone. Axial speed of sound (SOS) at the ulna bone was determined by QUS; bone mineral content (BMC) and bone mineral density (BMD) were determined by DXA. Correlations, regression analysis, and analyses of variance (ANOVAs) were used to compare the three modalities. These analyses revealed that although there are strong linear relationships among the data collected by the various technologies, the bone properties reflected by MRTA are not fully explained by DXA and QUS. We conclude that the total information conveyed by MRTA measurements is unique. Further research is needed to delineate the different qualities of bone strength that are captured by MRTA, but not by DXA or QUS. 相似文献
65.
目的 :探讨胃癌组织中微血管密度 (MVD)与胃癌生物学行为的关系。方法 :应用免疫组织化学S -P法和抗人因子Ⅷ相关抗原 (FⅧ -RAg)的抗体 ,标记 6 8例胃癌组织中的微血管 ,检测MVD。分析其与胃癌组织学类型、分化水平、浸润深度及淋巴结转移的关系。结果 :6 8例胃癌组织中FⅧ -RAg阳性表达 5 2例 ,占 76 .4 7%。FⅧ -RAg和MVD与分化水平、浸润深度 (P <0 .0 1)及淋巴结转移 (P <0 .0 0 1)密切相关。不同组织学类型中FⅧ-RAg的表达具有显著相关性 (P <0 .0 1) ,而MVD则与胃癌组织学类型无显著差异 (P >0 .0 5 )。 结论 :血管生成对胃癌的发展具有一定作用 ,FⅧ -RAg的检测和MVD可作为判断胃癌恶性程度和预后的生物学指标。 相似文献
66.
Bone mineral density (BMD, g/cm2) was measured using dual-photon absorptiometry (DPA) in selected areas of the proximal tibia following uncemented PCA knee prosthesis. In nine patients with 14 alloplastic operations, measurements were taken at 3-6-month intervals for the first 3 1/2 years after operation. There was a significant increase in BMD of about 15% during the first 6 months after operation. The following year it remained increased, although not significantly, compared with the initial values, then gradually diminished. Increased bone density after arthroplasty may be explained mainly by stimulation of bone formation from weight bearing due to improved walking ability. Stress shielding of the proximal part of the supporting tibial bone did not seem to occur. 相似文献
67.
Osteoporosis in men is recognised worldwide as an important and increasing public health problem. The causes are more heterogeneous than those in women. About 50% are diagnosed as secondary cases. In some secondary forms of osteoporosis the specific diagnosis results in additional therapeutic options (e.g. androgen therapy in proven hypogonadism). The basic therapy for osteoporosis in men is no different to that in postmenopausal women, namely recommendations for counteracting modifiable risk factors, especially with regard to diet, physical exercise, and calcium and vitamin D supplementation. Concerning specific drug medications, however, even today there is still a therapeutic dilemma in male osteoporosis. While older substances (e.g. calcitonin, fluoride, alfacalcidol) are approved for both sexes, all newer medications have primarily been approved for the treatment of postmenopausal osteoporosis. Health authorities request studies in purely male populations. For new drugs, fracture data are necessary while for new substances within a class (e.g. bisphosphonates), at the very least consistent effects on bone mineral density (BMD) and bone turnover markers are requested. Due to these regulatory rules, ibandronate, teriparatide and strontium ranelate are not approved in the European Union. Some years ago, alendronate was the first bisphosphonate that was approved for the treatment of men with osteoporosis, based on consistent results from two independent male studies using a daily 10 mg dosage. Very recently risedronate was approved by the FDA and EMEA. A randomised, placebo-controlled multicentre trial of 285 male patients showed, after 2 years, a 5.8% increase in lumbar spine BMD in the risedronate 35 mg once weekly group vs 1.2% in the placebo group. In a prospective controlled study on 316 men with primary or secondary osteoporosis we found, after 12 months, a lumbar spine BMD of +4.7% vs +1.0% in controls. The number of patients with one or more new vertebral fractures was 8 in the risedronate group and 20 in the placebo group (a fracture reduction of 60%). Furthermore, we found a significantly smaller decrease in height and a steeper decrease in back pain in the risedronate group. Risedronate is the first oral bisphosphonate available for men with the more comfortable once weekly dosage. 相似文献
68.
目的 探讨中国人过氧化物酶体增殖物激活受体γ(PPARγ)基因外显子6 C161T多态性与糖皮质激素性骨质疏松症(GIO)的相关关系。方法 应用聚合酶链反应-限制性片段长度多态性(PCR-RELP)方法测定208例正常健康人(Ⅰ组)、168例非GIO患者(Ⅱ组)和104例GIO患者(Ⅲ组)PPARγ基因外显子6 C161T的基因型。应用双能X线骨密度仪(DEXA)测定股骨、腰椎等部位的骨密度。 结果 外显子6 C161T有CC、CT、TT 3种基因型。GIO组CC基因型频率显著低于正常对照组;CT和TT基因型频率显著高于正常对照组。非GIO组、应用激素组(GIO组+非GIO组)与正常对照组比较,各基因型频率差异均无统计学意义。正常对照组C161T的CC基因型组各部位的骨密度有高于CT和TT基因型组的趋势,但差异无统计学意义。非GIO组和GIO组C161T的CC基因型组腰椎的骨密度明显高于CT和TT基因型组 (P < 0.05),分别为非GIO组CC型(1.04±0.17) g/cm2,CT+TT型(1.02±0.07) g/cm2;GIO组CC型(0.94±0.12) g/cm2,CT+TT型(0.83±0.08) g/cm2。经年龄、体重指数等因素校正后,差异仍有统计学意义(P < 0.05)。 结论 PPARγ基因C161T基因型在正常人和应用激素患者之间无明显差异,它可能与肾小球肾炎的发病无关。C161T基因型在GIO组和正常对照组之间差异有统计学意义,它可能与糖皮质激素性骨质疏松症的发病有关。PPARγ基因C161T多态性与应用糖皮质激素患者腰椎的骨密度有关。等位基因C可能是骨量的保护因子,它可能与应用糖皮质激素后骨量的丢失有关。 相似文献
69.
70.
老年冠心病患者止凝血功能与血脂的关系 总被引:1,自引:0,他引:1
目的探讨止凝血功能和血脂对老年冠心病患者发病的作用及其关系。方法采用ELISA法测定250例冠心病患者和80例对照者的凝血酶-抗凝血酶Ⅲ复合物(TAT)、血浆血管性血友病因子抗原(vWF:Ag)、P-选择素(P-selectin)、D-二聚体(D-D)水平,以Clauss法测定血浆纤维蛋白原(FG)水平,双抗体酶联免疫吸附法测定血浆Lp(a)浓度,并检测血清TC、TG、LDL-C、HDL-C水平。结果冠心病组血浆FG、TAT、vWF:Ag、P-selectin、D-D及血脂水平明显高于对照组(P<0.05);随着冠状动脉病变支数增加,除HDL-C逐渐降低外,其余指标均明显升高(P<0.05)。FG、LDL-C、Lp(α)与冠状动脉病变程度密切相关(P<0.05),且LDL-C、Lp(α)与FG水平相关。结论FG、LDL-C、Lp(α)是冠心病发病的独立危险因子,对冠心病发生和发展起协同促进作用;血浆FG、TAT、vWF:Ag、P-selectin、D-D浓度的动态连续监测对体内高凝状态和冠心病预防具重要意义;临床抗凝和降纤治疗与降脂治疗宜同时进行。 相似文献